Bayer Bets On Oncology Pipeline, Vows To Increase 2017 R&D Budget

 
• By Lucie Ellis-Taitt
  
Bayer Board
Bayer Execs In Leverkusen (L-R): Johannes Dietsch, Werner Baumann, Hartmut Klusik and Michael Preuss • Source: Scrip/ Lucie Ellis
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category